A Pharmacokinetic and Pharmacodynamic Assessment of Prasugrel in Healthy Adults and Adults With Sickle Cell Disease.
Phase of Trial: Phase I
Latest Information Update: 01 Feb 2014
At a glance
- Drugs Prasugrel (Primary)
- Indications Thrombosis
- Focus Pharmacokinetics
- 07 Jun 2017 Biomarkers information updated
- 15 Feb 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 14 Jan 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.